These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25054972)

  • 21. Long-term follow-up of benign multiple sclerosis in Hordaland County, Western Norway.
    Glad SB; Nyland HI; Aarseth JH; Riise T; Myhr KM
    Mult Scler; 2009 Aug; 15(8):942-50. PubMed ID: 19570821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Employment and Gainful Earnings Among Those With Multiple Sclerosis.
    Krause JS; Dismuke-Greer CE; Jarnecke M; Li C; Reed KS; Rumrill P
    Arch Phys Med Rehabil; 2019 May; 100(5):931-937.e1. PubMed ID: 30529324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Employment status in people with relapsing multiple sclerosis from Argentina: Impact of disability and neuropsychological factors.
    Carnero Contentti E; López PA; Pettinicchi JP; Tkachuk V; Balbuena ME; Caride A
    Work; 2021; 68(4):1171-1177. PubMed ID: 33867376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Burden of relapsing-remitting multiple sclerosis on workers in the US: a cross-sectional analysis of survey data.
    Nicholas JA; Electricwala B; Lee LK; Johnson KM
    BMC Neurol; 2019 Oct; 19(1):258. PubMed ID: 31660897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors influencing patients' willingness-to-pay for disease-modifying therapies for multiple sclerosis.
    Poudel N; Banjara B; Kamau S; Frost N; Ngorsuraches S
    Mult Scler Relat Disord; 2021 Feb; 48():102720. PubMed ID: 33429304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Onset of secondary progressive phase and long-term evolution of multiple sclerosis.
    Scalfari A; Neuhaus A; Daumer M; Muraro PA; Ebers GC
    J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):67-75. PubMed ID: 23486991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS.
    Rocca MA; Valsasina P; Meani A; Gobbi C; Zecca C; Rovira À; Montalban X; Kearney H; Ciccarelli O; Matthews L; Palace J; Gallo A; Bisecco A; Gass A; Eisele P; Lukas C; Bellenberg B; Barkhof F; Vrenken H; Preziosa P; Comi G; Filippi M;
    Neurology; 2019 Nov; 93(20):e1852-e1866. PubMed ID: 31611336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Profile of Polish patients with primary progressive multiple sclerosis.
    Brola W; Sobolewski P; Żak M; Flaga S; Fudala M; Siutka D; Kapica K; Chorąży M; Kułakowska A; Perenc A; Bartosik-Psujek H; Psujek M; Głąbiński A; Pawełczyk M; Gacek S; Potemkowski A
    Mult Scler Relat Disord; 2019 Aug; 33():33-38. PubMed ID: 31146082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased socioeconomic burden in patients with primary progressive multiple sclerosis: A Danish nationwide population-based study.
    Blinkenberg M; Kjellberg J; Ibsen R; Magyari M
    Mult Scler Relat Disord; 2020 Nov; 46():102567. PubMed ID: 33296969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results from SPECTRUM: A survey of healthcare professionals to understand current diagnosis and management practices for secondary progressive multiple sclerosis in the United Kingdom.
    Duddy M; Wilkinson C; Medhurst S; Rhys K
    Mult Scler Relat Disord; 2021 Oct; 55():103174. PubMed ID: 34399317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term influence of combined oral contraceptive use on the clinical course of relapsing-remitting multiple sclerosis.
    Gava G; Bartolomei I; Costantino A; Berra M; Venturoli S; Salvi F; Meriggiola MC
    Fertil Steril; 2014 Jul; 102(1):116-22. PubMed ID: 24794311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and diagnosis of Secondary Progressive Multiple Sclerosis during the clinical encounter: Results from a physician survey.
    Alvarez E; Nair KV; Gorritz M; Bartolome L; Maloney H; Ding Y; Golan T; Wade RL; Kumar R; Su W; Shah R; Russo P
    Mult Scler Relat Disord; 2021 May; 50():102858. PubMed ID: 33799068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cervical and thoracic cord atrophy in multiple sclerosis phenotypes: Quantification and correlation with clinical disability.
    Mina Y; Azodi S; Dubuche T; Andrada F; Osuorah I; Ohayon J; Cortese I; Wu T; Johnson KR; Reich DS; Nair G; Jacobson S
    Neuroimage Clin; 2021; 30():102680. PubMed ID: 34215150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for leaving employment due to multiple sclerosis and changes in risk over the past decades: Using competing risk survival analysis.
    Chen J; Taylor B; Blizzard L; Simpson-Yap S; Palmer AJ; Kirk-Brown A; Van Dijk P; van der Mei I
    Mult Scler; 2021 Jul; 27(8):1250-1261. PubMed ID: 32880529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The psychosocial and cognitive impact of longstanding 'benign' multiple sclerosis.
    Sayao AL; Bueno AM; Devonshire V; Tremlett H;
    Mult Scler; 2011 Nov; 17(11):1375-83. PubMed ID: 21677023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A mixed methods approach towards understanding key disease characteristics associated with the progression from RRMS to SPMS: Physicians' and patients' views.
    Ziemssen T; Tolley C; Bennett B; Kilgariff S; Jones E; Pike J; Tomic D; Piani-Meier D; Lahoz R
    Mult Scler Relat Disord; 2020 Feb; 38():101861. PubMed ID: 31865132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unmet needs of multiple sclerosis patients in the community.
    Lonergan R; Kinsella K; Fitzpatrick P; Duggan M; Jordan S; Bradley D; Hutchinson M; Tubridy N
    Mult Scler Relat Disord; 2015 Mar; 4(2):144-50. PubMed ID: 25787190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of visible and invisible symptoms on employment status, work and social functioning in Multiple Sclerosis.
    Lorefice L; Fenu G; Frau J; Coghe G; Marrosu MG; Cocco E
    Work; 2018; 60(2):263-270. PubMed ID: 29400690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome.
    Kantarci OH; Lebrun C; Siva A; Keegan MB; Azevedo CJ; Inglese M; Tintoré M; Newton BD; Durand-Dubief F; Amato MP; De Stefano N; Sormani MP; Pelletier D; Okuda DT
    Ann Neurol; 2016 Feb; 79(2):288-94. PubMed ID: 26599831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.